Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.12 | 0.7 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |